Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Phase 1
Not yet recruiting
- Conditions
- Geographic Atrophy
- Interventions
- Drug: BRX011Drug: Placebo
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Biojiva LLC
- Target Recruit Count
- 152
- Registration Number
- NCT07029945
RT001 in Amyotrophic Lateral Sclerosis
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Biojiva LLC
- Target Recruit Count
- 43
- Registration Number
- NCT04762589
- Locations
- πͺπͺ
University of Tartu, Tartu, Estonia
π±π»Riga Stradins Universtiy, Riga, Latvia
π³π±UMC Utrecht, Utrecht, Netherlands
News
No news found